About Us | Contact

Mr. Abubakar Ali Abdul-Rahman

Primary Care NPI1689939001
Update NPI

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$11,670.22
from 29 payments in the last 6 years

Total Cash or Cash Equivalent

$11,567.85
from 24 payments in the last 6 years

Total In-kind Items & Services

$102.37
from 5 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
08/03/2021 General (Non-Research) In-kind items and services Food and Beverage $19.96 Details
Payment from Vanda Pharmaceuticals Inc.
Payment Record ID 838916609
06/16/2021 General (Non-Research) In-kind items and services Food and Beverage $20.39 Details
Payment from Vanda Pharmaceuticals Inc.
Payment Record ID 838916607
05/06/2021 General (Non-Research) In-kind items and services Food and Beverage $18.93 Details
Payment from Vanda Pharmaceuticals Inc.
Payment Record ID 838916605
12/18/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $26.32 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405999
10/16/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $156.73 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405997
10/16/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $263.20 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405995
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $16.24 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405993
04/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $89.04 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405991
03/01/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $82.88 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405989
02/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $126.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405987
02/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $156.24 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405985
01/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $86.80 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405983
01/14/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $64.40 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405981
12/18/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405979
10/16/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $500.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405977
10/16/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405975
09/25/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405973
04/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $150.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405971
04/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405969
03/01/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405967
02/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $400.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405965
02/11/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405963
02/07/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405961
01/19/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405959
01/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405957
01/14/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $750.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405955
01/09/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $950.00 Details
Payment from Novartis Pharmaceuticals Corporation
Payment Record ID 814405953
08/03/2021 General (Non-Research) In-kind items and services Food and Beverage $13.05 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 788570521
05/15/2021 General (Non-Research) In-kind items and services Food and Beverage $30.04 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 788570519
;